Ushering an Antibody Cocktail, Designed to Reduce Antibody Resistance, to Trial as COVID-19 Therapy

Image: Selman Design Following two studies that screened thousands of human antibodies to SARS-CoV-2 to identify highly potent pairs, in which both antibodies bind the viral target simultaneously, a resultant antibody cocktail is being tested in human trials. The double-antibody approach, versus use of a single antibody, is designed not only to be effective as … Continue reading Ushering an Antibody Cocktail, Designed to Reduce Antibody Resistance, to Trial as COVID-19 Therapy